The Australian Brain Cancer market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Brain cancers include primary brain tumors, which start in the brain and almost never spread to other parts of the body, and secondary tumors (or metastases), which are caused by cancers that began in another part of the body. There are more than 40 major types of brain tumors, which are grouped into two main types they are benign and malignant. A brain tumor may be a primary or secondary cancer. Cancer that first develops in the brain is called primary brain cancer. It rarely spreads to other parts of the body but may spread to other parts of the brain. Sometimes cancer starts in another part of the body and then travels through the bloodstream to the brain. This is known as secondary cancer or metastasis. Every year an estimated 2000 malignant brain tumors are diagnosed in Australia. Malignant spinal cord tumors are rare. About 55 people are diagnosed with malignant spinal cord or other central nervous system tumors each year.
The market size drivers for the growth of brain cancer diagnostics are expected to propel by technological developments, improvements in diagnostics machines. The rise in the number of cigarette smokers responsible for brain cancer has contributed to the market size.
In 2019, the NDSHS reported current smokers aged 18 and over smoked an average of 12.9 cigarettes per day. Men and women smoked a similar number of cigarettes per day in 2019—an average of 13.1 and 12.9 cigarettes per day, respectively.
The population above 60 years of age forms the target demographic segment for this vertical, as this population subset is more prone to neurological conditions. The advancement of diagnostics equipment increases the lifespan of this demographic and improves the quality of life for those suffering from neurological conditions. Hence, the presence of a large geriatric population pool is considered a vital driver for this industry.
In 2016, there were 1,771 new cases of brain cancer diagnosed in Australia (1,062 males and 709 females). In 2020, it is estimated that 1,879 new cases of brain cancer will be diagnosed in Australia (1,113 males and 767 females).
In 2018, there were 1,410 deaths from brain cancer in Australia (845 males and 565 females). In 2020, it is estimated that there will be 1,518 deaths (921 males and 597 females).
In 2012–2016, individuals diagnosed with brain cancer had a 22 % chance (21% for males and 24% for females) of surviving for five years compared to their counterparts in the general Australian population.
At the end of 2015, there were 1,317 people living who had been diagnosed with brain cancer that year, 3,279 people living who had been diagnosed with brain cancer in the previous 5 years.